A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma
dc.creator | D'Agostino, L | |
dc.creator | Giordano, A | |
dc.date.accessioned | 2021-01-31T23:49:56Z | |
dc.date.available | 2021-01-31T23:49:56Z | |
dc.date.issued | 2011-01-01 | |
dc.identifier.issn | 1949-2553 | |
dc.identifier.issn | 1949-2553 | |
dc.identifier.doi | http://dx.doi.org/10.34944/dspace/5512 | |
dc.identifier.other | 22170762 (pubmed) | |
dc.identifier.uri | http://hdl.handle.net/20.500.12613/5530 | |
dc.description.abstract | NSP 5a3a is a novel structural protein found to be over-expressed in certain cancer cell lines in-vitro such as Hela, Saos-2, and MCF-7 while barely detectable levels in normal body tissues except for Testis. This particular isoform has been known to interact with cyto- nuclear proteins B23, known to be involved in multi-faceted cellular processes such as cell division, apoptosis, ribosome biogenesis, and rRNA processing, as well as with hnRNP-L, known to be involved with RNA metabolism and rRNA processing. A previous preliminary investigation of NSP 5a3a as a potential target in Head and Neck Carcinoma revealed a novel p73 dependent mechanism through which NSP 5a3a induced apoptosis in Head and Neck cell lines when overexpressed in-vitro. Our present investigation further elucidated a novel dual axis signaling point by which NSP 5a3a induces apoptosis in Head and Neck cell line HN30 through p73-DAXX and TRAF2-TRADD. Interestingly, this novel mechanism appears independent of canonical caspases involved in the intrinsic mitochondrial pathway as well as those in the death receptor pathway thru TRAF2 and TRADD. © D'Agostino et al. | |
dc.format.extent | 1055-1074 | |
dc.language.iso | en | |
dc.relation.haspart | Oncotarget | |
dc.relation.isreferencedby | Impact Journals, LLC | |
dc.rights | CC BY | |
dc.subject | NSP 5a3a | |
dc.subject | Head and Neck Carcinoma | |
dc.subject | TNFR-1 signaling pathway | |
dc.title | A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma | |
dc.type | Article | |
dc.type.genre | Journal Article | |
dc.relation.doi | 10.18632/oncotarget.306 | |
dc.ada.note | For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu | |
dc.creator.orcid | Giordano, Antonio|0000-0002-5959-016X | |
dc.date.updated | 2021-01-31T23:49:51Z | |
refterms.dateFOA | 2021-01-31T23:49:56Z |